Literature DB >> 31186524

Atezolizumab in understudied populations with bladder cancer.

Tyler F Stewart1, Daniel P Petrylak2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31186524     DOI： 10.1038/s41585-019-0200-8

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Efficacy of long-term extended nursing services combined with atezolizumab in patients with bladder cancer after endoscopic bladder resection.

Authors:  Yao Song; Pengjuan Ren; Yang Wu; Baodi Zhang; Junrong Wang; Yue Li
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

2.  Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice.

Authors:  Marina Mencinger; Dusan Mangaroski; Urska Bokal
Journal:  Radiol Oncol       Date:  2021-05-04       Impact factor: 2.991
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.